Minds → Drug & Pharmacy → How may Schedule III through V drugs be prescribed? Answer in under 100 words. Cite only eCFR (www.ecfr.gov) sources.
US Federal

How may Schedule III through V drugs be prescribed? Answer in under 100 words. Cite only eCFR (www.ecfr.gov) sources.

Under 21 CFR § 1306.21, as published in the eCFR (originally issued March 24, 1997; amended March 31, 2010), a pharmacist may dispense Schedule III–V controlled substances that are prescription drugs under section 503(b) of the Federal Food, Drug, and Cosmetic Act only pursuant to a written, facsimile, electronic, or oral prescription. An oral prescription must be promptly reduced to writing by the pharmacist with all § 1306.05 information except the signature.
Last verified: 2026-08-28 · Sources checked: 2/2 resolving · Next scheduled review: 2026-11-26

Details / How it works

Per 21 CFR § 1306.21(a), a pharmacist may dispense a Schedule III, IV, or V controlled substance that is a prescription drug (as determined under section 503(b) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 353(b)) only pursuant to one of four methods:

  1. A paper prescription signed by the practitioner;
  2. A facsimile (fax) copy of a signed paper prescription transmitted by the practitioner or the practitioner's agent to the pharmacy;
  3. An electronic prescription that meets the requirements of 21 CFR part 1306 and 21 CFR part 1311; or
  4. An oral (telephone) prescription made by an individual practitioner and promptly reduced to writing by the pharmacist, containing all information required in § 1306.05 except for the practitioner's signature.

Under § 1306.21(b), an individual practitioner may administer or dispense Schedule III–V substances directly in the course of professional practice without a prescription, subject to § 1306.07. Under § 1306.21(c), an institutional practitioner may administer or dispense (but not prescribe) such substances pursuant to a written prescription, fax, electronic prescription, oral prescription reduced to writing, or a medication order for immediate administration, subject to § 1306.07.

Exceptions & edge cases

  • Purpose of issue (21 CFR § 1306.04): A prescription for a Schedule III, IV, or V controlled substance must be issued for a legitimate medical purpose by an individual practitioner acting in the usual course of professional practice. A corresponding responsibility rests with the dispensing pharmacist. Prescriptions issued outside the usual course of treatment are not valid, and violators are subject to penalties under 21 U.S.C. §§ 841, 843.
  • Opioid use disorder treatment (§ 1306.04(c)–(d)): A practitioner may issue a Schedule III, IV, or V prescription for use in detoxification or maintenance treatment, provided the prescription complies with all applicable federal and state laws and the requirements of section 309A of the CSA (21 U.S.C. § 829a) and § 1306.07(f). Such prescriptions may not be used to supply a practitioner with stock for general dispensing to patients.
  • Institutional practitioners: Authorized to administer or dispense, but not to prescribe, Schedule III–V controlled substances.

Sources

  1. [1]U.S. Government Publishing Office / Drug Enforcement Administration — 21 CFR 1306.21 — Requirements for Schedule III-V controlled substance prescriptions · as of 2026-08-28
  2. [2]U.S. Government Publishing Office / Drug Enforcement Administration — 21 CFR 1306.04 — Purpose of a controlled substance prescription — corresponding responsibility · as of 2026-08-28

Ask this MIND

This answer is static and source-locked. Ask Drug & Pharmacy your version of this question.

Related questions

This is general information, not advice. Drug & Pharmacy summarizes primary sources (FDA, NIH/NLM, CDC) as of the dates shown. It is not tax/legal/immigration advice and doesn’t account for your situation. Consult a qualified professional before acting. About this MIND

This page is one mind’s knowledge, published.

MIND turns your documents into a queryable, citable knowledge graph.

Make your own MIND →
Content licensed CC BY 4.0 · Attribution: "Source: MIND (m-i-n-d.ai)" · License terms
© 2026 MIND · m-i-n-d.ai · All Minds · Drug & Pharmacy · License · Privacy · Terms